ACADIA PHARMACEUTICALS INC
ACAD
26 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Jun 29 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Sale | 11,421 | $26.08 | $297.9K | 13,088(D) | View → |
| Jun 26, 2026 | Jun 26 7:09 PM | Kihara James | Proposed Sale | 11,421 | $26.00 | $297.0K | — | View → |
| May 26, 2026 | May 27 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Sale | 5,401 | $21.18 | $114.4K | 24,509(D) | View → |
| May 26, 2026 | May 26 8:02 PM | JAMES K KIHARA | Proposed Sale | 5,401 | $21.18 | $114.4K | — | View → |
| May 4, 2026 | May 5 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Sale | 1,332 | $21.79 | $29.0K | 29,129(D) | View → |
| May 4, 2026 | May 5 10:00 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Sale | 3,506 | $21.79 | $76.4K | 66,145(D) | View → |
| Apr 7, 2026 | Apr 7 11:57 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Sale | 2,709 | $22.20 | $60.1K | 62,836(D) | View → |
| Apr 7, 2026 | Apr 7 11:55 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Sale | 1,030 | $22.20 | $22.9K | 27,865(D) | View → |
| Mar 25, 2026 | Mar 27 12:00 AM | Adams Catherine OwenDirector, Chief Executive Officer | Sale | 11,641 | $21.47 | $249.9K | 14,803(D) | View → |
| Mar 25, 2026 | Mar 27 12:00 AM | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | Sale | 3,435 | $21.47 | $73.7K | 3,280(D) | View → |
| Mar 25, 2026 | Mar 27 12:00 AM | Jennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC | Sale | 3,844 | $21.47 | $82.5K | 11,280(D) | View → |
| Mar 26, 2026 | Mar 27 12:00 AM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Sale | 1,109 | $21.65 | $24.0K | 26,885(D) | View → |
| Mar 25, 2026 | Mar 27 12:00 AM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Sale | 833 | $21.47 | $17.9K | 25,852(D) | View → |
| Mar 26, 2026 | Mar 27 12:00 AM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Sale | 3,208 | $21.65 | $69.5K | 60,269(D) | View → |
| Mar 25, 2026 | Mar 27 12:00 AM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Sale | 4,177 | $21.47 | $89.7K | 57,299(D) | View → |
| Feb 9, 2026 | Feb 10 11:00 PM | Jennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC | Sale | 6,950 | $23.38 | $162.5K | 7,609(D) | View → |
| Nov 10, 2025 | Nov 10 10:59 PM | James M Daly | Proposed Sale | 30,000 | $22.37 | $671.0K | — | View → |
| Aug 18, 2025 | Aug 18 8:31 PM | Schneyer Mark C. | Proposed Sale | 22,000 | $25.33 | $557.3K | — | View → |
| Jun 4, 2025 | Jun 4 8:35 PM | LAURA BREGE | Proposed Sale | 14,446 | $21.78 | $314.6K | — | View → |
| May 16, 2025 | May 16 9:10 PM | Schneyer Mark C. | Proposed Sale | 2,000 | $17.60 | $35.2K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Jun 2 8:32 PM | BAKER BROS. ADVISORS LPDirector, 10% Owner | Grant/Award | 64,016 | $21.66 | 32,008(I) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Edmund HarriganDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Edmund HarriganDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Adora NduDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Adora NduDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Laura BregeDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Laura BregeDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Jonathan PooleDirector | Option Exercise | 2,010 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Jonathan PooleDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Elizabeth A. GarofaloDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Elizabeth A. GarofaloDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | James M DalyDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | James M DalyDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 1, 2026 | May 5 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Option Exercise | 2,596 | — | 2,596(D) | View → |
| May 1, 2026 | May 5 10:00 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Option Exercise | 6,815 | — | 6,815(D) | View → |
| Apr 5, 2026 | Apr 7 11:57 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Option Exercise | 5,276 | — | 0(D) | View → |
| Apr 5, 2026 | Apr 7 11:55 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Option Exercise | 2,010 | — | 0(D) | View → |
| Mar 24, 2026 | Mar 27 12:00 AM | Adams Catherine OwenDirector, Chief Executive Officer | Option Exercise | 23,509 | — | 70,530(D) | View → |
| Mar 24, 2026 | Mar 27 12:00 AM | Jennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC | Option Exercise | 7,515 | — | 22,547(D) | View → |
| Mar 24, 2026 | Mar 27 12:00 AM | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | Option Exercise | 6,715 | — | 20,146(D) | View → |
Page 1 of 2
Next →